Protein Kinase C Activity and Hexamethylenebisacetamide-induced Erythroleukemia Cell Differentiation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1987 Aug 1

PMID 3474654

Citations 25

Authors

E Melloni

S Pontremoli

M Michetti

O Sacco

A G Cakiroglu

J F Jackson

R A Rifkind

P A Marks

Affiliations

Soon will be listed here.

Abstract

Hexamethylenebisacetamide (HMBA) is a potent inducer of murine erythroleukemia (MEL) cell differentiation. The mechanism of action of HMBA is not known. In this study we provide evidence that protein kinase C has a role in inducer-mediated MEL cell differentiation: (i) HMBA induces the formation of a soluble, proteolytically activated form of protein kinase C that is catalytically active in the absence of Ca2+ and phospholipid; (ii) the protease inhibitor leupeptin blocks formation of this activated form of the kinase and inhibits HMBA-induced MEL cell hemoglobin accumulation; (iii) phorbol 12-myristate 13-acetate (PMA) inhibits HMBA-induced MEL differentiation and causes depletion of total protein kinase C activity; (iv) MEL cells depleted in protein kinase C activity by culture with PMA are resistant to induction by HMBA; (v) upon removal of PMA, restoration of MEL cell sensitivity to HMBA is correlated with reaccumulation of protein kinase C activity; and (vi) MEL cells grown to density arrest are both depleted of protein kinase C activity and resistant to HMBA. Together, these results suggest that HMBA-mediated MEL cell differentiation involves a protein kinase C-related mechanism and the proteolytically activated form of the kinase, which does not require Ca2+ or phospholipid for its catalytic activity.

Citing Articles

A Novel Approach Based on Metabolomics Coupled With Intestinal Flora Analysis and Network Pharmacology to Explain the Mechanisms of Action of Bekhogainsam Decoction in the Improvement of Symptoms of Streptozotocin-Induced Diabetic Nephropathy in Mice.

Meng X, Ma J, Kang A, Kang S, Jung H, Park Y Front Pharmacol. 2020; 11:633.

PMID: 32508632 PMC: 7253635. DOI: 10.3389/fphar.2020.00633.

Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gastric cancer cells during differentiation induced by traditional Chinese medicines.

Gu S, Liang Y, Fan L, Li B, Wang D World J Gastroenterol. 2016; 3(1):50-3.

PMID: 27006587 PMC: 4796840. DOI: 10.3748/wjg.v3.i1.50.

Defective erythropoiesis in a mouse model of reduced Fbxo7 expression due to decreased p27 expression.

Randle S, Nelson D, Patel S, Laman H J Pathol. 2015; 237(2):263-72.

PMID: 26095538 PMC: 4583784. DOI: 10.1002/path.4571.

Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation.

Klichko V, Archin N, Kaur R, Lehrman G, Margolis D J Virol. 2006; 80(9):4570-9.

PMID: 16611917 PMC: 1472000. DOI: 10.1128/JVI.80.9.4570-4579.2006.

Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells.

Iwasaki K, MacKenzie E, Hailemariam K, Sakamoto K, Tsuji Y Mol Cell Biol. 2006; 26(7):2845-56.

PMID: 16537925 PMC: 1430308. DOI: 10.1128/MCB.26.7.2845-2856.2006.

References

Chen Z, Banks J, Rifkind R, Marks P . Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process. Proc Natl Acad Sci U S A. 1982; 79(2):471-5. PMC: 345765. DOI: 10.1073/pnas.79.2.471. View

Sheffery M, Rifkind R, Marks P . Murine erythroleukemia cell differentiation: DNase I hypersensitivity and DNA methylation near the globin genes. Proc Natl Acad Sci U S A. 1982; 79(4):1180-4. PMC: 345925. DOI: 10.1073/pnas.79.4.1180. View

Melloni E, Sparatore B, Salamino F, Michetti M, Pontremoli S . Cytosolic calcium dependent proteinase of human erythrocytes: formation of an enzyme-natural inhibitor complex induced by Ca2+ ions. Biochem Biophys Res Commun. 1982; 106(3):731-40. DOI: 10.1016/0006-291x(82)91772-7. View

Kraft A, Anderson W, Cooper H, Sando J . Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells. J Biol Chem. 1982; 257(22):13193-6. View

Kishimoto A, Kajikawa N, Shiota M, NISHIZUKA Y . Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J Biol Chem. 1983; 258(2):1156-64. View

Feuerstein N, Cooper H . Rapid protein phosphorylation induced by phorbol ester in HL-60 cells. Unique alkali-stable phosphorylation of a 17,000-dalton protein detected by two-dimensional gel electrophoresis. J Biol Chem. 1983; 258(17):10786-93. View

Nakaki T, Mita S, Yamamoto S, Nakadate T, Kato R . Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1984; 44(5):1908-12. View

Coussens L, Parker P, Rhee L, Yang-Feng T, Chen E, Waterfield M . Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science. 1986; 233(4766):859-66. DOI: 10.1126/science.3755548. View

Ramsay R, Ikeda K, Rifkind R, Marks P . Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A. 1986; 83(18):6849-53. PMC: 386607. DOI: 10.1073/pnas.83.18.6849. View

10.

Pontremoli S, Melloni E, Salamino F, Sparatore B, Michetti M, Sacco O . Phosphorylation of proteins in human neutrophils activated with phorbol myristate acetate or with chemotactic factor. Arch Biochem Biophys. 1986; 250(1):23-9. DOI: 10.1016/0003-9861(86)90697-1. View

11.

Marks P, Sheffery M, Rifkind R . Induction of transformed cells to terminal differentiation and the modulation of gene expression. Cancer Res. 1987; 47(3):659-66. View

12.

Ohno S, Kawasaki H, Imajoh S, Suzuki K, Inagaki M, Yokokura H . Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature. 1987; 325(7000):161-6. DOI: 10.1038/325161a0. View

13.

Sibley D, Benovic J, Caron M, Lefkowitz R . Regulation of transmembrane signaling by receptor phosphorylation. Cell. 1987; 48(6):913-22. DOI: 10.1016/0092-8674(87)90700-8. View

14.

NISHIZUKA Y . The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984; 308(5961):693-8. DOI: 10.1038/308693a0. View

15.

Fujiki H, Tanaka Y, Miyake R, Kikkawa U, NISHIZUKA Y, Sugimura T . Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: teleocidin and debromoaplysiatoxin. Biochem Biophys Res Commun. 1984; 120(2):339-43. DOI: 10.1016/0006-291x(84)91259-2. View

16.

Couturier A, Bazgar S, Castagna M . Further characterization of tumor-promoter-mediated activation of protein kinase C. Biochem Biophys Res Commun. 1984; 121(2):448-55. DOI: 10.1016/0006-291x(84)90203-1. View

17.

Miyake R, Tanaka Y, Tsuda T, Kaibuchi K, Kikkawa U, NISHIZUKA Y . Activation of protein kinase C by non-phorbol tumor promoter, mezerein. Biochem Biophys Res Commun. 1984; 121(2):649-56. DOI: 10.1016/0006-291x(84)90231-6. View

18.

NISHIZUKA Y . Turnover of inositol phospholipids and signal transduction. Science. 1984; 225(4668):1365-70. DOI: 10.1126/science.6147898. View

19.

Pincus S, Beckman B, George W . Inhibition of dimethylsulfoxide-induced differentiation in Friend erythroleukemic cells by diacylglycerols and phospholipase C. Biochem Biophys Res Commun. 1984; 125(2):491-9. DOI: 10.1016/0006-291x(84)90567-9. View

20.

Arcoleo J, Weinstein I . Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium. Carcinogenesis. 1985; 6(2):213-7. DOI: 10.1093/carcin/6.2.213. View